Healthcare provider profile · identity verified

Kapil Pokharel, MD

Family Practice · JACKSONVILLE, FL · NPI 1164050357

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	498	238
Gabapentin	Gabapentin	335	142
Losartan Potassium	Losartan Potassium	316	144
Amlodipine Besylate	Amlodipine Besylate	301	143
Diclofenac Sodium	Diclofenac Sodium	253	176
Albuterol Sulfate Hfa	Albuterol Sulfate	207	89
Omeprazole	Omeprazole	171	89
Meloxicam	Meloxicam	167	103
Metoprolol Succinate	Metoprolol Succinate	148	75
Trazodone Hcl	Trazodone Hcl	128	58
Carvedilol	Carvedilol	121	61
Furosemide	Furosemide	116	56
Metformin Hcl	Metformin Hcl	111	48
Lisinopril	Lisinopril	104	47
Rosuvastatin Calcium	Rosuvastatin Calcium	97	46
Duloxetine Hcl	Duloxetine Hcl	96	57
Fluticasone Propionate	Fluticasone Propionate	95	51
Tizanidine Hcl	Tizanidine Hcl	95	62
Hydrochlorothiazide	Hydrochlorothiazide	83	43
Alendronate Sodium	Alendronate Sodium	82	36
Pantoprazole Sodium	Pantoprazole Sodium	81	52
Tamsulosin Hcl	Tamsulosin Hcl	78	42
Mirtazapine	Mirtazapine	77	44
Levothyroxine Sodium	Levothyroxine Sodium	74	29
Sildenafil Citrate	Sildenafil Citrate	71	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	30
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	65	49
Metformin Hcl Er	Metformin Hcl	64	26
Nifedipine Er	Nifedipine	62	30
Potassium Chloride	Potassium Chloride	59	27
Spironolactone	Spironolactone	56	22
Eliquis	Apixaban	51	17
Glipizide	Glipizide	51	27
Triamcinolone Acetonide	Triamcinolone Acetonide	49	31
Bupropion Hcl Sr	Bupropion Hcl	41	23
Hydralazine Hcl	Hydralazine Hcl	41	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	14
Oxybutynin Chloride Er	Oxybutynin Chloride	38	22
Metoprolol Tartrate	Metoprolol Tartrate	32	14
Allopurinol	Allopurinol	31	17
Pravastatin Sodium	Pravastatin Sodium	31	14
Clopidogrel	Clopidogrel Bisulfate	30	16
Montelukast Sodium	Montelukast Sodium	29	18
Ondansetron Odt	Ondansetron	29	26
Jardiance	Empagliflozin	27	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Famotidine	Famotidine	23	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	11
Buspirone Hcl	Buspirone Hcl	22	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	22	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Sertraline Hcl	Sertraline Hcl	20	14
Clonidine Hcl	Clonidine Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fluconazole	Fluconazole	19	15
Labetalol Hcl	Labetalol Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Baclofen	Baclofen	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Ofloxacin	Ofloxacin	16	11
Oxybutynin Chloride	Oxybutynin Chloride	16	12
Atenolol	Atenolol	15	suppressed
Azithromycin	Azithromycin	15	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Donepezil Hcl	Donepezil Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Levofloxacin	Levofloxacin	14	13
Linzess	Linaclotide	14	suppressed
Ozempic	Semaglutide	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Colchicine	Colchicine	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Etodolac	Etodolac	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Nystatin	Nystatin	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Simvastatin	Simvastatin	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error